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Anthrax lethal toxin is a classical AB toxin comprised
of two components: protective antigen (PA) and
lethal factor (LF). Here, we show that following
assembly and endocytosis, PA forms a channel that
translocates LF, not only into the cytosol, but also
into the lumen of endosomal intraluminal vesicles
(ILVs). These ILVs can fuse and release LF into the
cytosol, where LF can proteolyze and disable host
targets. We find that LF can persist in ILVs for days,
fully sheltered from proteolytic degradation, both
in vitro and in vivo. During this time, ILV-localized
LF can be transmitted to daughter cells upon cell
division. In addition, LF-containing ILVs can be deliv-
ered to the extracellular medium as exosomes.
These can deliver LF to the cytosol of naive cells in
a manner that is independent of the typical anthrax
toxin receptor-mediated trafficking pathway, while
being sheltered from neutralizing extracellular fac-
tors of the immune system.INTRODUCTION
Anthrax lethal toxin (LT), a major Bacillus anthracis virulence fac-
tor, is comprised of two protein subunits: lethal factor (LF) and
protective antigen (PA) (van der Goot and Young, 2009). LF is a
metalloprotease capable of cleaving most MAPK kinases
(MAPKKs) (Collier and Young, 2003) as well as Nod-like receptor
Nlrp1 (Levinsohn et al., 2012). These activities lead to the inter-
ruption of most MAPK signaling pathways and to the activation
of Nlrp1 inflammasomes, respectively. The PA component has
no cytotoxic activity of its own, but it is required for the cellular
uptake and translocation of LF (van der Goot and Young,986 Cell Reports 5, 986–996, November 27, 2013 ª2013 The Authors2009). PA binds to specific anthrax toxin receptors (ATRs). A
furin-like protease can cleave off a 20 kDa domain in PA, allowing
the remaining 63 kDa portion (PA63) to self-assemble into ring-
shaped oligomers (van der Goot and Young, 2009). These PA
oligomers can then bind up to four LF subunits (van der Goot
and Young, 2009). Receptor-bound hetero-oligomeric PA-LF
complexes are taken up by clathrin-mediated endocytosis
(Abrami et al., 2010). Under acidic endosomal conditions, the
PA oligomer inserts into the membrane and forms a translocase
channel, which unfolds and translocates LF across the mem-
brane (Feld et al., 2012).
Based on the observations that channel formation by PA
occurred in early endosomes, but delivery of LF to the cytosol
appeared to involve transport to late endosomes (Abrami et al.,
2004), we have proposed that channel formation by PA not
only occurs in the limiting membrane of early endosomes as
for other toxins but preferentially occurs in the membrane of
intraluminal vesicles (ILVs) (Abrami et al., 2004). Early and late
endosomes are indeed multivesicular organelles (Falguie`res
et al., 2009; Huotari and Helenius, 2011), where ILVs form
through the sequential action of the ESCRTs (endosomal-sorting
complexes required for transport). ESCRTs induce an inward
invagination of the compartment’s limiting membrane and sub-
sequent pinching off of the nascent vesicle (Hurley and Hanson,
2010). In the current model for anthrax toxin trafficking (Abrami
et al., 2004), PA-mediated translocation of LF can bring the enzy-
matic toxin subunit into the lumen of ILVs. These vesicles and
their contents are delivered to late endosomes and then poten-
tially lysosomes (Falguie`res et al., 2009). This pathway provides
a mechanism for the degradation of ILV components, i.e., mem-
brane proteins and lipids. However, some proteins that transit
through ILVs can escape degradation and are recycled through
back fusion of ILVs to the late-endosome limiting membrane
(Falguie`res et al., 2009). Previously, we proposed that anthrax
LT can hijack this ILV back fusion as a mechanism for release
of LF to the cytosol (Abrami et al., 2004).
Figure 1. LF Is Degraded in the Cytosol by
the Proteasome in a Translocation-Depen-
dent Manner
RPE1 cells were pretreated (B and D–F) or not
(A and C) with 10 mM MG132 for 45 min or treated
with 250 mg/ml leupeptin (Leu) for 8 hr or left
untreated (Ctrl). Cells were then treated with PA83
WT (A, B, and E) or F427A (C, D, and F) and LF
for 1 hr, and then incubation was performed with
toxin-free medium for different time points. PNSs
(40 mg) were analyzed by SDS-PAGE and western
blotting for LF, PA monomer (PAmono), PA SDS-
resistant-oligomer (PAoligo), and the N terminus of
MEK1 (MEK1-N). (B and D) LF levels were quanti-
fied using the Typhoon or Fusion Imager and
normalized to the level of LF at 1 hr p.t.t. Error bars
represent the SD.In addition to delivery to lysosomes and back fusion, a third
fate has been proposed for ILVs—delivery to the extracellular
milieu. Released ILVs are called exosomes (Raposo and
Stoorvogel, 2013). Due to their origin, exosomes are small,
low-density, extracellular vesicles, 40–100 nm in diameter; their
lumen is topologically equivalent to the cytoplasm. These
vesicles are present in all body fluids, have the capacity to
present antigens, and are proposed to function in autocrine
and paracrine cell-to-cell communication (Raposo and Stoor-
vogel, 2013). Interestingly, exosomes can also selectively
incorporate microRNAs (miRNAs) upon ILV formation, allowing
cell-to-cell transmission of miRNAs (Gibbings et al., 2009;
Raposo and Stoorvogel, 2013). Furthermore, exosomes have
been proposed to promote spreading of prion proteins (Vella
et al., 2007) and a-synuclein-mediated Parkinson disease
(Danzer et al., 2012).
Here, we provide evidence supporting our proposed model
of LF targeting to ILVs. We show that a major advantage
of such a complex delivery route is that it allows the toxin
to have long-term action, for up to a week, by effectively
sheltering LF in ILVs. We also show that a population of
LF-bearing ILVs is released into the medium as exosomes,
which are efficiently taken up by naive cells. We charac-
terize the molecular requirements for both the biogenesis and
release of these exosomes as well as for their uptake in recip-
ient cells.Cell Reports 5, 986–996, NRESULTS
LF Degradation Occurs in the
Cytoplasm after Its Delivery from
Late Endosomes
Anthrax PA, like the B subunit of most
AB toxins, undergoes a conformational
change at the acidic pH of endosomes
that leads to membrane insertion and for-
mation of a translocation pore (Collier and
Young, 2003). Membrane insertion of the
PA pore could potentially occur either in
the limiting membrane of early endo-
somes, as for diphtheria toxin, or in themembrane of ILVs that form in early endosomes along the matu-
ration/transport process to late endosomes (Huotari and Helen-
ius, 2011). We previously proposed that the latter preferentially
occurs, after sorting of the toxin-receptor complex into the
nascent ILVs (Abrami et al., 2004). This hypothesis was based
on the observations that PA can be detected by electron micro-
scopy in ILVs and that LF-mediated cleavage of the MAPKK
MEK1 was sensitive to depolymerization of microtubules by
nocodazole, consistent with a requirement for transport from
early to late endosomes.
We sought here to further test the hypothesis that the majority
of LFs are first translocated by PA into the lumen of ILVs in early
endosomes and later released from the ILVs to the cytosol at the
level of late endosomes. For these studies, we chose to analyze
the cellular pathway(s) that leads to degradation of LF. When
human retinal pigmented epithelial 1 (RPE1) cells, which express
both ATRs ANTXR1 and ANTXR2 (van der Goot and Young,
2009), are treated with LT (i.e., PA plus LF) for 1 hr and subse-
quently incubated for different periods of time in toxin-free
medium, cell-associated LF levels decrease with a half-life
(t1/2) of 3 hr (Figures 1A and 1B). We tested whether this decay
was dependent on the translocation of LF via the PA channel. We
used the PAF427A mutant, which is known to be translocation
deficient (Krantz et al., 2005) but is otherwise properly sorted
and trafficked. Consistently, upon treatment of cells with
PAF427A and LF, binding and formation of the oligomeric poreovember 27, 2013 ª2013 The Authors 987
Figure 2. LF Degradation Is Governed by Its
Translocation into ILVs
(A and B) RPE1 cells were transfected with siRNA
against SNX3, or VSVG as a control (Ctrl siRNA).
On day 3 posttransfection, cells were pretreated
with 10 mM MG132 for 45 min or 250 mg/ml leu-
peptin (Leupep.) for 8 hr or were left untreated
(Ctrl). Cells were treated with LT, followed by in-
cubation in toxin-free medium for different time
points. PNSs (40 mg) were analyzed by SDS-PAGE
and western blotting for LF. LF levels were quan-
tified using the Fusion Imager and normalized to
the level of LF at 1 hr. Error bars represent the SD.
(C–E) Schematic representation shows anthrax LF
in endosomes when escorted by PAWT (C) or
PAF427A (E) under control conditions or by PAWT in
SNX3 siRNA-treated cells (D). The PA oligomer is
represented in yellow for PAWT and in red for
PAF427A. LF is shown in orange. The proteasome
is in light blue (sensitive to MG132); lysosomal
enzymes are in dark blue (sensitive to leupeptin).
See also Figure S1.(PAoligo) occurred similarly as observed with PA wild-type
(PAWT), but cleavage of LF’s target, MEK1, was not observed,
indicating that LF did not reach the cytosol (Figures 1A and
1C). When LF was escorted by PAF427A, its degradation rate
was rapid (t1/2 2 hr) (Figure 1D) in comparison to its t1/2 of
3 hr when escorted by PAWT (Figure 1B). In the absence
of translocation, i.e., when escorted by PAF427A, LF is topo-
logically retained in the endosomal lumen. Consistently, its
degradation was rescued by treatment with a lysosomal prote-
ase inhibitor, leupeptin (Figures 1D and 1F). Again, this rescue
was striking in comparison to PAWT-escorted LF, where the LF
decay kinetics were completely insensitive to leupeptin (Figures
1B and 1E). In contrast, PAWT-escorted LF was rescued by the
proteasome inhibitor, MG132 (Figures 1B and 1E), whereas
PAF427A-escorted LF was not (Figures 1D and 1F). Taken
together, these observations show the following: (1) when LF is
not translocated via PA, LF is degraded efficiently by leupep-
tin-sensitive lysosomal enzymes; (2) translocation of LF by
PAWT is highly efficient in cells, consistent with in vitro transloca-
tion studies (Thoren and Krantz, 2011), and this translocation
event protects LF from lysosomal enzymes; and (3) when
escorted by PAWT, LF is degraded in the cytosol by the protea-
some. These results are fully consistent with the observation988 Cell Reports 5, 986–996, November 27, 2013 ª2013 The Authorsthat the toxicity of LT is mediated by the
N-end rule (Gupta et al., 2008).
To further isolate the mechanism of LF,
we found its degradation to be sensitive
to nocodazole (Figure S1), consistent
with the proposal that transport to late
endosomes is important for the release
of LF to the cytosol. The fact that nocoda-
zole does not fully block LF degradation
could be due to a minor LF population
that is translocated to the cytosol from
early endosome following insertion of PA
into the limiting membrane. With the aimof forcing all release of LF to the cytosol at the level of early endo-
somes, we silenced sorting nexin, SNX3, a PI3P-binding PX
domain-containing protein involved in the biogenesis of ILVs in
early endosomes (Pons et al., 2008). SNX3 silencing led to an
acceleration of LF degradation (t1/2 2 hr) (Figure 2A), where
the observed degradation was lysosomal protease independent
(leupeptin insensitive), proteasome dependent (MG132 sensi-
tive) (Figure 2B), and nocodazole insensitive (Figure S1). These
observations are consistent with the following hypothesis: in
SNX3-silenced cells, early endosomes are devoid of ILVs, and
thus, insertion of PA only in the limiting membrane of this
compartment leads to translocation of LF directly into the
cytosol, effectively bypassing the requirement for transport to
late endosomes (Figure 2D). The accelerated degradation of LF
in SNX3-silenced cells suggests that transport of LF to late endo-
somes, counterintuitively, stabilizes LF, by delaying its release to
the cytosol.
To summarize, the analyses of LF degradation support the
following scenario: the toxin-receptor complex is endocytosed
and transported to early endosomes, where it can be sorted
into nascent ILVs (Figure 2C). There, due to the sufficiently low
pH, PA inserts into the ILV membrane to form a channel, which
translocates LF into the ILV lumen. Upon transport/maturation
Figure 3. Exposure to Anthrax LT Leads to Prolonged MAPKK
Cleavage
(A) RPE1 cells were treated with or without LT, and then incubation was per-
formed in toxin-free medium for various amounts of time. PNSs (40 mg) were
analyzed by SDS-PAGE and western blotting for MEK1 N terminus (MEK1-N),
MKK3 C terminus (MKK3-C), LF, PA monomer (PAmono), PA SDS-resistant-
oligomer (PAoligo), and tubulin (as an equal loading control).
(B) Western blots show cleavage of MEK1 and MEK2 N terminus at various
times post PA plus LF treatment (45 mg each, i.v.) in mice. The asterisk (*)
indicates a cross-reactive band indicative of equal loading.
(C) Control RPE1 cells were treated with or without LT for 1 hr and then
incubated in toxin-free medium for various times. A second set of RPE1 cells
was pretreated 2 hr before toxin addition with 100 nM bafilomycin A (Baf A).
After toxin treatment, these cells were incubated at room temperature for 5min
with acid buffer at pH 4.5 to allow toxin entry through the plasma membrane
(acid) in the presence of bafilomycin. PNSs (40 mg) were analyzed by
SDS-PAGE and western blotting with antibodies against LF and the
MEK1 N terminus. Actin level was used to assess equal loading. Levels of
MEK1 N-terminal reactive bands were quantified using the Typhoon Imager
and normalized to 100% with nontreated cells. Error bars represent the SD.
(D) RPE1 cells were transfected with siRNA against SNX3, or VSVG as a control
() for 3 days before the of LT or medium, followed by washes and incubation
in toxin-free medium for several hours. The isolated PNSs (40 mg) were
analyzed by SDS-PAGE and western blotting for the MEK1 N terminus
(MEK1-N), MKK3 C terminus (MKK3-C), and tubulin (loading control) levels.
See also Figures S2 and S3.to/into late endosomes, ILV-encapsulated LF reaches late endo-
somes where occasional fusion events between ILVs and the
late-endosomal limiting membrane, so-called back fusion, leads
to the release of LF into the cytosol. Here, LF can cleave its
targets, yet is then also vulnerable to degradation by the protea-
some with a half-life of 2 hr or less. If through some perturbation
ILVs fail to form in early endosomes, then membrane insertion of
PA only occurs in the limiting membrane of the compartment,
and PA directly translocates LF into the cytosol (Figure 2D).
When translocation is blocked or perturbed, LF is degraded by
lysosomal enzymes (Figure 2E). The mechanism by which LF
undergoes degradation is thus fully governed by the site of
PA membrane insertion and the translocation capacity of the
PA pore.
Small Reservoir of LF Has Long-Term Potency in Target
Cells
Because LF is degraded with an apparent half-life of 3 hr, we
analyzed how much time was required for the recovery of typical
LF targets, such as MAPKKs. Unexpectedly, recovery of full-
length MAPKKs required >8 days in RPE1 cells (Figure 3A). The
number of days to recovery was dependent on the LF concentra-
tion (FigureS2A).Similarobservationsweremade inmacrophages
(Ha et al., 2007), HeLa, BHK (L.A., unpublished data), and primary
human umbilical vein endothelial cells (HUVECs, Figure S2B).
The low MAPKK levels observed between days 1 and 7 are
not due to a feedback mechanism on the transcription of these
kinases because real-time qPCR analysis showed that the
mRNA levels of MEK1 (Figure S3A, left panel) and MKK3 (Fig-
ure S3A, right panel) were not reduced in toxin-treated cells.
Consistently, synthesis of MKK3 was normal in toxin-treated
cells as measured by metabolic pulse labeling (Figure S3B). To
test whether the absence of full-length MAPKKs during this
long time period is due to processing by LF, we performed
35S-Cys-Metmetabolic pulses, followed by immunoprecipitation
of MKK3. These experiments, described in the Supplemental
Experimental Procedures and Figures S3C and S3D, indicate
that MKK3 underwent LF-mediated cleavage and, thus, that LF
is present in these cells at day 5, even though LF was undetect-
able by western blotting. Many bacterial toxins contain enzymes
known to be highly efficient (Alouf and Freer, 2005), e.g., one
diphtheria toxin molecule is sufficient to kill one host cell. Thus,
we find that a small reservoir of enzymatically active LF is main-
tained in host cells for a long period, retaining the capability to
access and cleave the toxin’s cytosolic substrates.
Wenext testedwhether a similar long-termeffect of LTcouldbe
observed in vivo.Micewere injected intravenously (i.v.) with a sin-
gle dose of PA plus LF that leads to death within 4 days.With this
dose, PA is no longer measurable in circulation at 16 hr by ELISA
orwestern blot (M.M., unpublisheddata). Animalswere sacrificed
at different times, and the MAPKK levels were monitored in
various tissues, in particular the heart, which is a major target
organ of LT (Liu et al., 2013). Although full-length MAPKKs were
clearly detected in the organs from control mice, representative
LF targets, MEK1 and MEK2, were processed in organs from
toxin-treatedmice for at least 3 days (Figure 3B).WhenLFwas in-
jected into mice in the absence of PA, MEK1 andMEK3 were not
processed over the extended 3-day period (Figure S2C).CeFormation of the Long-Term LF Reservoir Requires ILV
Biogenesis
The long-term activity of LF in cells could potentially be
explained by the persistent recycling of a small population of
toxin-receptor complexes via the cell surface. We previously
had shown that anthrax toxin endocytosis is clathrin mediatedll Reports 5, 986–996, November 27, 2013 ª2013 The Authors 989
and requires the GTPase dynamin (Abrami et al., 2010). Silencing
of dynamins 1 and 2 at 24 hr posttoxin treatment (p.t.t.), how-
ever, did not prevent long-term cleavage of MAPKKs (Fig-
ure S4A), indicating that the LF reservoir is not a recycling toxin
pool.
To explain the persistent action of LF, we therefore hy-
pothesized that some LF molecules remain in the lumen of
ILVs and that these vesicles slowly release their LF contents
over the course of several days. The ILV lumen would protect
the LF from breakdown because this environment is devoid
of lysosomal enzymes and access by the proteasome. Our
hypothesis that ILVs constitute a small LF reservoir leads to
the following predictions: persistent LF action should be lost
if (1) LF bypasses ILVs, and (2) the dynamics of IVLs are
perturbed.
LF can be artificially introduced into the cytosol, bypassing the
endocytic pathway by briefly pulsing LT-pretreated cells with
acidic pH (Slater et al., 2013). We added the vacuolar ATPase in-
hibitor bafilomycin A during LT pretreatment to ensure that none
of the toxin complexes enters through endocytosis. Bafilomycin
A, which prevents pH-induced PA membrane insertion, com-
pletely inhibits LF-induced MEK1 cleavage (Figure S4B). LF
translocation across the plasma membrane using this pH-pulse
approach was highly effective because MEK1 cleavage was
shown to be complete (Figure 3C); however, in contrast to con-
trol cells, recovery of unprocessed MEK1 was detectable within
7 hr (Figure 3C).
Next, we silenced SNX3 to force PA channel formation in the
limiting early-endosomal membrane resulting in direct transloca-
tion of LF into the cytosol. Under these conditions, full recovery
of MEK1 was observed within 16 hr (Figure 3D). Taken together,
these observations validate the first prediction of our ILV-LF
storage model: when LF is delivered directly to the cytosol, LF
activity is lost within 16 hr as opposed to 7–8 days when the
late-endosomal ILV-dependent route is taken.
Multivesicular Endosome Membrane Dynamics Are
Required for Long-Term LF Activity
We next investigated the effects of manipulating endosome
membrane dynamics. The fact that LF-mediated MAPKK cleav-
age takes place for over 7–8 days permits manipulation of
membrane-trafficking steps several days after toxin endocy-
tosis, and PA pore formation and LF translocation have been
completed, thus specifically addressing release of LF from
ILVs to the cytosol.
We first interfered with endosome dynamics by applying the
vacuolar ATPase inhibitor, bafilomycin A, exactly 4 days fol-
lowing LT treatment (Figure 4A). Acidic pH is indeed essential
for endosome dynamics (Huotari and Helenius, 2011). Remark-
ably, at day 4 p.t.t., MEK1 and MKK3 recovery was observed
within 4 hr of bafilomycin A addition to RPE1 cells (Figure 4B)
or HUVECs (Figure S5).
To further interfere with ILV membrane dynamics, cells were
fed an antibody against the unconventional, late-endosome-
specific lipid lysobisphosphatidic acid (LBPA). Treatment with
anti-LBPA causes the accumulation of ILVs and of cholesterol
(Kobayashi et al., 1998). Treatment of cells with the negatively
charged amine 3b-(2-diethylaminoethoxy)-androstenone HCl990 Cell Reports 5, 986–996, November 27, 2013 ª2013 The Authors(U18666A) similarly induces cholesterol accumulation. Four
days after LT exposure, cells were treated with U18666A or
anti-LBPA (Figure 4C). These treatments allowed full recovery
of MAPKK levels at day 5 p.t.t. (Figure 4C), indicating that
manipulation of endosomal lipid composition altered the delivery
of LF to the cytosol. Interestingly, MAPKK cleavage resumed
upon U18666A washout (Figure 4C). These data are consistent
with the model that the LF activity was trapped within a popula-
tion of ILVs that were unable to release their content to the
cytosol due to the altered lipid composition of the endocytic
compartment.
Alix is a protein partner of the LBPA lipid (Falguie`res et al.,
2009; Matsuo et al., 2004). Alix is also known to interact with
the ESCRT machinery and is required for ILV formation (Fal-
guie`res et al., 2009;Matsuo et al., 2004) and the cytosolic release
of LF (Abrami et al., 2004). At day 2 p.t.t. (Figure 4A), cells were
transfected with siRNAs against Tgs101 (a component of
ESCRT I), Alix (which interacts with ESCRT III) (Hurley and Han-
son, 2010), or SNX3. The late-endosomal scaffolding protein
(p14) was used as a negative control. In a separate set of cells,
at day 3 p.t.t. (Figure 4A), we overexpressed a dominant-nega-
tive form of Vps4, the AAA-ATPase involved in the last (scission)
step in ILV formation (Hurley and Hanson, 2010). A GTP-locked
form of small GTPase Sar1a involved in ER to Golgi transport
was used as a negative control. Silencing of Tsg101, Alix, or
SNX3, but not of p14, led to the complete recovery of MEK1
and MKK3 levels within the 2–3 days required for gene silencing,
i.e., at day 5 (Figure 4D). Similarly, overexpression of dominant-
negative Vps4, but not of Sar1, resulted in recovery of the
MAPKKs (Figure 4D). As for U18666A, these treatments
appeared to trap LF in the ILVs. Indeed, at day 7, the domi-
nant-negative Vps4 was no longer expressed (Figure 4D, fifth
row), and concomitantly, cleavage of theMAPKKs resumed (Fig-
ure 4D, last lane, day 7). Thus, when endosomal membrane
dynamics were altered several days after toxin endocytosis
and PA-mediated LF translocation had taken place, the long-
term reservoir of active LF was rendered inaccessible, prevent-
ing LF from acting on its cytosolic targets.
LF Can Be Delivered to Naive Cells via Exosomes
Wenext testedwhether LF was also released frommultivesicular
endosomes to the outside medium packaged within exosomes.
To detect the exosome-packaged LF, we chose a functional
approach, investigating whether LF could be transmitted to
naive (non-toxin-treated) cells either in coculture experiments
or by the use of conditioned medium (CM) from toxin-treated
cells. One day after LT treatment, primary intoxicated RPE1 cells
were cocultured either with naive RPE1 cells or naive Chinese
hamster ovary cells deficient in ATRs (CHODATR) (Abrami et al.,
2010). Complete cleavage of MEK1 and MKK3 was observed
even when cells were plated at a 1:7 ratio of toxin-treated cells
to naive cells (Figure 5A). As a control, we verified that mixing
postnuclear supernatants (PNSs) from toxin-treated and naive
cells does not lead to MAPKK cleavage (data not shown). Simi-
larly, when the CM from toxin-treated RPE1 cells was added to
either RPE1 or CHODATR cells, complete MAPKK cleavage was
observed (Figure 5B), indicating that LF had been delivered to
the cytosol in an ATR- and PA-independent manner. (Also note
Figure 4. Alteration of the MAPKK Recovery Kinetics upon Inter-
ference with ILV Dynamics
(A) Schematic representation shows the timeline of the experiments aimed at
affecting ILV dynamics. Over Exp., overexpression; Drug/Ab, Drug/antibody;
treat., treatment.
(B) RPE1 cells were incubated or not (Ctrl) with LT, followed by toxin-free
medium for 4 days. At day 4, 100 nM of bafilomycin A was added to the cells in
complete medium, and cell extracts were prepared at the indicated time
points. PNSs extracted from the samples (40 mg) were analyzed by SDS-PAGE
and western blotting against MEK1-N, MKK3-C, and tubulin. This is a repre-
sentative experiment of three similar studies.
(C) RPE1 cells were incubated with or without LT for 1 hr, followed by toxin-
free medium for 4 days. On day 4, samples were collected; U18666A (U18.)
or anti-LBPA was added to the cells in complete medium for 24 hr. On day 5,
samples were collected, or cells that had been treated with U18666A were
washed for 24 hr and collected at day 6 (U18. without). PNSs extracted
from the samples (40 mg) were analyzed by SDS-PAGE and western blotting
Cewell that 1 hr after LT addition, the medium was changed to re-
move free toxin subunits.) Interestingly, cleavage of MAPKKs
in naive cells occurred within 2 hr of exposure to the CM, and
LF-mediated cleavage activity persisted for at least 4 days (Fig-
ure 5B). Hence, this mode of delivery is rapid, independent of the
PA translocation machinery, and capable of acting over long dis-
tances; this exosome delivery system also allows LF to be stored
over long periods of time in the naive recipient cells.
To confirm that LF was present in exosomes, as opposed to
free in the medium, CM was submitted either to high-speed
centrifugation or separation using a flotation density gradient.
As shown in Figures 5C and 5D, LF was recovered in the pellet
of the high-speed centrifugation, whereas it was recovered
from the low-density fractions of the flotation gradient, both indi-
cating that LF was associated with amembrane fraction. The LF-
containing floated fractions also contained Alix, Tgs101, and
Flotillin 1 (Figure 5D), three proteins that have been found in exo-
somes by several proteomics studies (Raposo and Stoorvogel,
2013), but were devoid of PA (data not shown). Finally, we found
that in the CM, LF was protected from protease digestion unless
membranes were disrupted with digitonin (Figure 5E).
Biogenesis of LF-Bearing Exosomes
To further dissect the biogenesis pathway of LF-bearing exo-
somes, we silenced genes involved in ILV formation in early
endosomes (SNX3, Alix, or Tsg101) 3 days prior to toxin addition.
As expected, MAPKKs were cleaved in these cells after 4 hr in
all cases (Figure 6A, top panel), confirming that toxin sensitivity
had been retained. MAPKK levels recovered in these SNX3-,
Alix-, or Tgs101-silenced cells 24 hr p.t.t. (Figure 6A, middle
panel), consistent with the notion that upon impairment of ILV
formation, LF is translocated by PA directly into the cytosol
across the limiting membrane of endosomes and, thus, rather
shorted lived. Interestingly, CM from these silenced cells failed
to trigger MAPKK cleavage in naive RPE1 cells (Figure 6A,
bottom panel) and consistently did not contain detectable
amounts of LF (Figure 6B). The CM, however, did contain Flotillin
1, indicating that these cells do release exosomes (Figure 6B),
consistent with a previous observation that Alix and ESCRTs
are not essential for exosome biogenesis (Trajkovic et al.,
2008). Thus, generation of LF-containing exosomes is depen-
dent upon SNX3, Alix, and Tsg101, as was found for the
generation of miRNA-loaded (Gibbings et al., 2009) and syntenin
exosomes (Baietti et al., 2012).against MEK1-N,MKK3-C, and tubulin. A representative experiment of three is
shown.
(D) RPE1 cells were treated with or without LT for 1 hr and then incubated in
toxin-free medium. On day 2, cells were transfected with siRNA against
TSG101, SNX3, Alix, p14, or VSVG as a control (Ctrl), or left untreated. Note
that as opposed to in Figures 2 and 3, SNX3 was silenced 2 days after toxin
treatment here. On day 3, a second set of toxin-treated cells was transfected
with SAR1a-GTP cDNA or VPS4 DN cDNA (day 5). On day 5, PNSs were ex-
tracted and analyzed by SDS-PAGE (40 mg of protein per lane) followed by
western blotting against MEK1-N, MKK3-C, TSG101, Alix, VPS4 DN-GFP, and
tubulin as an equal loading control. PNSs from VPS4 DN-expressing cells were
also extracted on day 7 and analyzed as above. This is a representative
experiment of three with similar findings.
See also Figures S4 and S5.
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Figure 5. LF Is Present in the Extracellular
Medium of Toxin-Treated Cells
(A) On day 0, RPE1 cells or CHO DATR (which
lacks ATRs) was incubated with LT or medium and
then in toxin-free medium for 1 day. On day 1,
RPE1 and CHO DATR were mixed at the indicated
ratio. On day 4, PNSs (40 mg) were analyzed by
SDS-PAGE and western blotting for MEK1-N,
MKK3-C, and actin.
(B) On day 0, RPE1 cells were treated with LT,
followed by washes and incubated in toxin-free
medium for 1 day. On day 1, the CM from RPE1-
treated cells was collected and added to non-
treated RPE1 cells or nontreated CHO DATR cells
for different times as indicated. PNSs (40 mg) were
analyzed by SDS-PAGE and western blotting
against MEK1-N, MKK3-C, and actin.
(C) RPE1 cells were incubated with LT, followed by
toxin-free medium for 1 day. After 1 day, the CM
from RPE1-treated cells was collected and ultra-
centrifuged for 1 hr at 100,000 3 g at 4C. The
pellet and the acetone-precipitated supernatant
(Sup.) were dissolved in sample buffer and were
analyzed and compared with one-tenth of the CM
by SDS-PAGE andwestern blotting against LF and
Flotillin 1.
(D) RPE1 cells were incubated with LT, followed by
toxin-free medium for 1 day. After 1 day, the CM
from RPE1-treated cells was collected and loaded
on the bottom of a sucrose step gradient (30%/40%/15% sucrose). After 2 hr of ultracentrifugation at 100,000 3 g at 4C, six fractions were collected
from the top, precipitated, and analyzed by SDS-PAGE and western blotting for LF, Alix, TSG101, and Flotillin 1.
(E) RPE1 cells were incubatedwith LT, followed by toxin-freemedium for 1 day. After 1 day, the CM fromRPE1-treated cells was collected and treatedwith trypsin
and/or digitonin for 30 min at room temperature. Samples were analyzed by SDS-PAGE and western blotting performed for Alix and LF. All experiments in this
figure are representative of at least three experiments.We next sought conditions where biogenesis ILV in early
endosomes occurs normally, but release of exosomes from
MVBs at the plasma membrane is impaired. Several small
GTPases from the Rab family have been proposed to be involved
in exosome release (Raposo and Stoorvogel, 2013). Rab11 was
found to be required for exosome biogenesis in reticulocytes, but
it is unclear whether Rab11 is involved in MVB fusion or biogen-
esis (Savina et al., 2002). Rab27a and Rab27b were found to be
involved in exosome formation in HeLa cells engineered to
perform MHC class II-mediated antigen presentation (Ostrowski
et al., 2010), and Rab35 was found to affect exosome secretion
in oligodendroglial cells (Hsu et al., 2010). Silencing of these
three Rab proteins was efficient (Figure S6A) and did not affect
the sensitivity of cells to LF as witnessed by MAPKK cleavage
4 hr after toxin treatment (Figure 6A, top panel). One day p.t.t.,
MAPKKs were still cleaved (Figure 6A, middle panel), indicating
that silencing of these Rab does not phenocopy silencing of
SNX3, Alix, and Tgs101. This further suggests that Rab silencing
does not affect targeting of LF to the lumen of ILVs or subsequent
ILV back fusion and LF release to the cytosol. Consistent with
this, we found that LF degradation kinetics were not affected
by Rab silencing (Figure S6B), as opposed to SNX3 silencing
(Figure 2A). However, CM from Rab11- or Rab35-silenced cells
failed to trigger MAPKK cleavage in naive RPE1 cells (Figure 6A,
bottom panel), and consistently, the CM was devoid of LF (Fig-
ure 6B). As opposed towhatwe observedwhen silencing ESCRT
components (Alix, Tsg101), silencing of Rab11 or Rab35 pre-992 Cell Reports 5, 986–996, November 27, 2013 ª2013 The Authorsvented exosome formation, as witnessed by the absence of
Flotillin 1 in the CM (Figure 6B). Silencing of Rab27a had no effect
in these assays (Figures 6A and 6B). Thus, Rab 11 and Rab35,
but not Rab27, are required for the delivery of LF-loaded exo-
somes to extracellular medium in RPE1 cells.
Our study reveals that in the primary intoxicated cells, LF-
loaded ILVs have three fates: (1) back fusion with the limiting
membrane leading to release of LF to the cytosol, (2) release
into the extracellular space as exosomes, and (3) storage in late
endosomes to undergo back fusion or exosome release at later
times. Treatment of the recipient cells with the proteasome inhib-
itor MG132 led to a 75%–80% rescue of LF at 4 and 6 hr postin-
toxication, respectively (Figures 1B, 1D, and S6C). To estimate
the amount of LF that is released through exosomes, we
compared the amount of cell-associated LF over time in control
cells versus cells in which exosome release was prevented by
Rab35/Rab11 silencing (Figure S6D). The amount of cell-associ-
ated LF was 30% higher in cells where Rab35 or Rab 11 had
beensilenced (FigureS6D).Thesepercentagesare ratherapprox-
imate given the limited quantitative capacity of western blot ana-
lyses, but they clearly indicate that, whereas the majority of LFs
reached the cytosol of the primary intoxicated cells, a significant
amount of LFs is released from RPE1 cells within exosomes.
Delivery of LF-Loaded Exosomes
We next investigated how exosomes deliver LF to the recipi-
ent cells. Two mechanisms for exosome delivery have been
Figure 6. LF Is Present in Exosomes
(A) RPE1 cells were transfected or not with siRNA
against TSG101, SNX3, Alix, RAB11, RAB27a,
RAB35, or VSVG as a control (Ctrl). After 3 days,
RPE1 cells were incubated or not (Ctrl) with LT,
followed by toxin-free medium for 4 hr or 1 day.
After 1 day, CM from RPE1-treated cells was
collected and added to naive RPE1 cells. For each
condition, PNS (40 mg) was analyzed by SDS-
PAGE and western blotting against MEK1-N,
MKK3-C, and actin.
(B) The level of LF and Flotillin 1 was analyzed by
SDS-PAGE and western blotting in the CM
described above in (A).
(C) Naive RPE1 cells were transfected with siRNA
against TSG101, Alix, Dynamins 1 and 2, Rab27a,
Rab27b, Rab35, Rab11, or VSVGas acontrol (Ctrl).
After 2 days of transfection, these cells received
CM from toxin-treated control RPE1 cells. One day
later, PNSs (40 mg) were analyzed by SDS-PAGE
and western blotting against MEK1-N, MKK3-C,
and actin. All experiments in this figure are repre-
sentative of at least three experiments.
See also Figure S6.proposed: direct fusion with the plasma membrane of the recip-
ient cells, or uptake by endocytic mechanisms (Raposo and
Stoorvogel, 2013). The prolonged MAPKK cleavage observed
in exosome-treated naive cells (Figure 5B) suggests that LF is
not delivered to the cytoplasm through direct fusion with the
plasma membrane (because this would lead to rapid proteaso-
mal degradation) unless extracellular exosomes are extremely
stable. To probe for a role of endocytosis, we silenced dynamins,
which have been shown tomediate reticulocyte exosome uptake
bymacrophages (Barre`s et al., 2010). Silencing of dynamins pre-
vented LF-containing exosomes from triggering MAPKK cleav-
age (Figure 6C), supporting a role for endocytosis in LF delivery
from LF-containing exosomes to naive cells.
Because uptake of an exosome by endocytosis de facto leads
to an intraendocytic vesicle, reminiscent of ILVs generated by the
ESCRT pathway, we tested whether silencing Alix or Tsg101
would affect LFdelivery. As shown in Figure 6C, silencingof either
of thesecomponents in thenaiveRPE1cellspreventedexosome-
delivered LF-inducedMAPKK processing, whereas silencing any
of the Rab proteins (11, 27a or b, 35) had no effect. Thus, LF-con-
taining exosomes are taken up by recipient cells through a dyna-
min-dependent mechanism that subsequently relies, directly or
indirectly, on the ESCRT machinery (precisely Alix and Tgs101)
for release of LF to the cytosol. Thus, the requirements for LF to
reach the cytosol appear to be similar in either case: (1) when
LF is present in ILVs of the primary toxin-treated cell, and (2)
whenLF is present in exosomesendocytosedby a naive recipient
cell. These requirements are consistentwith the fact that the envi-
ronment and topologies are identical in the two situations.
In our experimental setup, cells that have been treated with PA
plus LF for 1 hr can subsequently also take up LF-loaded exo-
somes in an autocrine fashion. To determine whether the long-
term effect we observe on MAPKK cleavage (Figure 3A) is
preferentially due to ATR-dependent delivery of LF (i.e., through
ILVs) or to uptake of LF-containing exosomes, we treated cells
with toxin for 1 hr, silenced dynamins 1 day postinfection to pre-Cevent the cells from taking up exosomes, and monitored the
MAPKK levels 5–8 days later. Kinetics of MAPKK recovery
were essentially identical to that of control cells (Figure S4A
versus Figure 3A). Thus, the long-term effect observed in primary
intoxicated cells (Figure 7) is not due to the fact that these cells
can take up LF-loaded exosomes but rather to the slow release
of the endogenous ILV LF pool.
DISCUSSION
Previous studies on the differential sites of PA pore formation
and cytoplasmic delivery of LF led us to the hypothesis that LF
can be translocated by PA into the lumen of ILVs (Abrami
et al., 2004). This hypothesis was supported by electron micro-
scopy and immunolabeling studies on cultured cells. We now
provide additional strong evidence that this model accurately
describes anthrax toxin trafficking. By analyzing the relative con-
tributions of lysosomal enzymes and the proteasome to the
degradation of LF in target cells, we show that persistent LF re-
sides in an environment that is free of lysosomal enzymes, where
it can remain active for days, and is degraded only once it has
been delivered to the cytosol. Further supporting an ILV localiza-
tion of LF, we show that LF can be found inside exosomes and
that exosomes can mediate delivery of LF to naive cells. Our
model of anthrax toxin trafficking is diagrammed in Figure 7.
The reason why PA channels preferentially insert in the mem-
brane of ILVs rather than the limiting endosomal membrane is
intriguing and probably relates to pH. We have previously
observed that in cells expressing a temperature-sensitive muta-
tion in epsilon-COP, in which early endosomes become highly
tubular at the restrictive temperature and early to late endosomal
transport is blocked, PA channels do not form (Abrami et al.,
2004). By contrast, in cells silenced for SNX3, where endosomes
retain cisternal regions, albeit are devoid of ILVs, membrane
insertion of PA does occur (this study). Taken together, these ob-
servations suggest that cisternal regions in early endosomes arell Reports 5, 986–996, November 27, 2013 ª2013 The Authors 993
Figure 7. Schematic Representation of the Long-Term and Long-Distance LF Delivery Modes
Anthrax LT is internalized via a dynamin-dependent pathway and delivered to early endosomes. There, the toxin-receptor complex is sorted into nascent ILVs.
Anthrax PA forms a channel into the membrane of the ILV and translocates LF into the lumen. LF, encapsulated in the ILVs, is transported in a microtubule-
dependent manner to later stages of the endocytic pathway. There, two fates are observed: LF is either delivered to the cytosol, presumably by back fusion, over
periods of days, or LF-containing ILVs are released into the extracellular medium as exosomes. These exosomes can be taken up by naive recipient cells via an
ATR-independent dynamin-dependent mechanism. LF is subsequently released into the cytosol of the recipient cell in a Tgs101- and Alix-dependent manner
(inspired by Raposo and Stoorvogel, 2013).required for PA pore formation. Because the toxin-receptor com-
plex is sorted into ILVs, due to kinetic reasons, PA pore formation
occurs preferentially in ILVs.
How LF is subsequently delivered from the lumen ILVs to the
cytosol is not clear, but undoubtedly, LF delivery requires a
membrane-fusion event, and thus, the simplest scenario is that
the ILVs undergo back fusion with the limiting membrane of
late endosomes (Falguie`res et al., 2009). Although back fusion
of LF-containing ILVs may occur in a controlled fashion, we pro-
pose that this process is stochastic and defined by an exponen-
tial decay. Initially after exposure of the cells to the toxin, when
the number of LF-loaded ILVs is higher, there is a faster effective
release of toxin into the cytosol; however, as the LF-loaded ILVs
are depleted, the rate of LF release diminishes. The size of endo-
somes indeed remains relatively constant, and the pool of ILVs is
continuously replenished to compensate for delivery to lyso-
somes and back fusion. Thus, the probability that back fusion
of an LF-loaded ILV occurs decreases exponentially with time
but in principle never reaches zero. In the late stage of this ILV-
unloading process, a relatively minute population of LFs is all
that is required to ensure that LFs’ MAPKK substrates are
cleaved, given the high potency of the enzyme.
Our findings have a number of implications in different fields.
First, they show that LF remains present in cells long after they
have been exposed to the toxin, despite the short cytosolic LF
half-life. This extended presence is important because, with
few exceptions, anthrax LT (despite the implied meaning behind994 Cell Reports 5, 986–996, November 27, 2013 ª2013 The Authorsits name) generally does not kill cells, with the exception of some
mousemacrophages. LF cleaves proteins that cells continuously
synthesize (the half-life of MEK1 and MKK3 is 2 hr; L.A., unpub-
lished data). Prolonged toxic effects thus require prolonged toxin
presence. The intracellular persistence of LF is likely to be partic-
ularly important early during infection when the circulating toxin
concentration is low and the bacterium aims at efficiently
neutralizing the host immune response (Baldari et al., 2006).
Our findings also provide an explanation for the early observa-
tions of Smith and colleagues that following infection, even after
B. anthracis had been cleared by antibiotics, anthrax LT is still
active (Smith and Keppie, 1954). It has been observed that the
half-life of LF in the blood stream might be long (Boyer et al.,
2007). Our findings suggest that the LF has an even longer
half-life once it localizes to ILVs/exosomes.
Our current findings probably also extend to the second
anthrax toxin, edema toxin, which is composed of PA and edema
factor (EF), a calmodulin-dependent adenylate cyclase respon-
sible for edema in patients with anthrax. Because both LF and
EF rely on PA to reach their destination, both enzymatic subunits
should reach the lumen of ILVs.
Our study also shows that LF can be transmitted from cell to
cell via exosomes, potentially allowing for the long-distance
action. This transmission route might further contribute to the
long half-life of LF observed in infected mice. Also, it may allow
the toxin to transfer from cell to cell without the possibility for
neutralization by the host immune system. It might also allow
the toxin to gain access to body sites that are not reachable by
the bacillus or circulating soluble toxin components (PA, LF,
and EF). The in vivo relevance of LF- and EF-loaded exosomes
during an infection will require further investigation.
Two prior studies report association of protein toxins with
exosomes, revealing that the pathway is generally available for
exploitation. The first study proposed that upon plasma mem-
brane permeation by Staphylococcal a toxin, the injured cell
takes up the toxin pores by endocytosis, sequesters them in
ILVs, and regurgitates them to the extracellular space in exo-
somes, failing to degrade pores in lysosomes (Husmann et al.,
2009). The second study reports cell-to-cell transmission of the
plant toxin trichosanthin (TCS) via exosomes. As opposed to
LF, TCS, which lacks a PA-like translocase component, travels
on the external side of exosomes, accessible to host immune
components. How this topology allows delivery of TCS to the
host cytosol to occur is unclear.
The long-term localization of LF to ILVs or exosomes that we
describe has therapeutic implications. Although anti-PA or anti-
LF vaccines or antibodies have proven useful in protecting from
anthrax infection, our findings indicate that they are unlikely to
be useful to fully cure an established infection. In support of our
model, it was shown that LF inhibitors could protect rabbits using
a ‘‘pointofnoreturn’’model inwhichantibiotic treatmentconferred
50%protection (Shoop et al., 2005). In this study, rabbits received
an antibiotic treatment combined or not with an LF inhibitor.
Although the bacteria were cleared in both situations, only mice
that received the combined treatment survived. Similar results
were found in mice (Moayeri et al., 2013). Targeting ILVs or exo-
some-localizedLF requiresmembrane-permeable smallmolecule
LF inhibitors or drugs that lead to depletion of the LF-storage pool.
Finally, our work provides information regarding the endocytic
and exosomal pathways of the host.We characterize the biogen-
esis of LF-loaded exosomes as dependent on SNX3, Alix, and
Tgs101, whereas their release at the plasmamembrane depends
on Rab11 and Rab35, but not Rab27. The LF-containing exo-
somes are then taken up by a dynamin-dependent mechanism
that transports the exosomes to the endocytic pathway from
which LF is released into the cytoplasm of the recipient cell again
in an Alix- and Tgs101-dependent manner. Back fusion of the
exosome with the limiting endosomal membrane is the most
likely scenario for LF release, providing strong evidence that
such a mechanism does indeed take place in cells.
What our study also reveals is that not all MVBs mature into
lysosomes. The fact that 7 days after toxin exposure, the entire
cellular pool of MEK1 and MKK3 still undergoes LF-mediated
cleavage, even when the exosomal uptake route is blocked by
dynamin silencing, indeed indicates that all the cells in the pop-
ulation have LF. During the time course of our experiments,
toxin-treated cells, however, undergo approximately five rounds
of cell division (Figure S7). Thus, for cells to contain LF, theymust
have received it from their mothers. Because the half-life of LF in
the cytosol is short, delivery must have occurred through segre-
gation of multivesicular endosomes into daughter cells. Thus,
the persistence of LF during cell division suggests the existence
of a stable population of multivesicular endosomes.
In summary, this study reveals how the unusual intracellular
trafficking route of anthrax toxin leads to the generation of aCepersistent toxin pool that ensures prolonged toxicity as well as
possible transmission to distant cells via exosomes. This work
paves the road to future in vivo studies addressing the impor-
tance of IVLs and exosomes in the lethality of anthrax toxin as
well as furthering the molecular dissection of ILVs/exosomes.
EXPERIMENTAL PROCEDURES
Cells
RPE1 cells were grown in complete DMEM (GIBCO) supplemented with 10%
fetal calf serum (FCS), 2 mM L-glutamine, penicillin, and streptomycin. CHO
DATR cells lacking ATR were grown as described (Liu and Leppla, 2003).
Toxins and Reagents
WT PA and LF were produced as described (Liu and Leppla, 2003). Recombi-
nant PAWT and PAF427A were produced by overexpression in E. coli as
described by Feld et al. (2012). Cells were treated with LT, i.e., 500 ng/ml
PA83 and 25 ng/ml LF, for 1 hr at 37
C. To trigger PA insertion in the
plasma membrane, cells were incubated at room temperature for 5 min with
145 mM NaCl and 20 mM MES-Tris (pH 4.5).
Bafilomycin A was purchased from Sigma-Aldrich and used at a final
concentration of 100 nM in complete medium. Nocodazole and MG132
were purchased from Sigma-Aldrich and used at a final concentration of
10 mM. Leupeptin was purchased fromRoche and used at a final concentration
of 250 mg/ml.
Digitonin from Sigma-Aldrich was used at 50 mg/ml. Trypsin was from
Sigma-Aldrich; U1866A (3 mg/ml for 24 hr) was from Biomol Research
Laboratories.
Total Cell Extracts, Immunoprecipitations, and Western Blot
Analysis
The PNSs were produced and analyzed by western blotting as described
(Abrami et al., 2010) using the antibodies summarized in the Supplemental
Experimental Procedures. Protein quantification was performed with BCA re-
agents from Pierce. ECL substrates were used (Pierce) and quantified using a
Typhoon Imager (GE Healthcare), except for in Figure 3B, a LiCoR Odyssey
Infrared Imager (Li-COR Biosciences) was used.
Transfections and Real-Time PCR
Plasmid-encoding human VPS4 DNK173Q cloned in peGFP-C1 was provided
by Dr. J. Gruenberg and SAR1a-GTP cloned in pCDNA3 by Dr. R. Watanabe
(University of Geneva). Plasmids were transfected for 48 hr (2 mg cDNA/
9.6 cm2 plate) using FuGENE (Roche). For gene silencing by RNAi, siRNA pur-
chased from QIAGEN (Table S1 for sequences) was transfected for 72 hr with
100 pmol/9.2 cm2 dish using interferin transfection reagent (Polyplus). For real-
time qPCR, RNA from cells was extracted 3 days post-siRNA transfection
using the RNAeasy kit (QIAGEN) as described (Abrami et al., 2010).
Intoxication of Mice
C57BL/6J mice were injected with PBS or LT (45 mg LF plus 45 mg PA, i.v.), and
at 24, 48, and 76 hr posttoxin, organs were perfused with PBS and collected in
liquid nitrogen.Organswere lysed inRIPAbuffer containing aprotease inhibitor
cocktail (Roche) using a Tissue Tearor Homogenizer (BioSpec) and processed
for western blotting. Animal experiments were approved by NIAID ACUC.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.10.019.
ACKNOWLEDGMENTS
We thank Nuria Reig for early experiments; Laura Symul for generating the
models; J. Gruenberg for reagents, advice, and critical reading of the manu-
script; Reika Watanabe for the SAR1a-GTP cDNA; and all the members ofll Reports 5, 986–996, November 27, 2013 ª2013 The Authors 995
the F.G.v.d.G. laboratory for their helpful suggestions and discussions. This
work was supported by the Swiss National Science Foundation and the
NCCR Chemical Biology (to F.G.v.d.G.), NIAID grant 2R01 AI077703-05 (to
B.A.K.), and the intramural research programs of the NIAID and the NHLBI,
NIH (to S.H.L.).
Received: July 16, 2013
Revised: October 1, 2013
Accepted: October 11, 2013
Published: November 14, 2013
REFERENCES
Abrami, L., Lindsay, M., Parton, R.G., Leppla, S.H., and van der Goot, F.G.
(2004). Membrane insertion of anthrax protective antigen and cytoplasmic
delivery of lethal factor occur at different stages of the endocytic pathway.
J. Cell Biol. 166, 645–651.
Abrami, L., Bischofberger, M., Kunz, B., Groux, R., and van der Goot, F.G.
(2010). Endocytosis of the anthrax toxin is mediated by clathrin, actin and
unconventional adaptors. PLoS Pathog. 6, e1000792.
Alouf J.E. and Freer J.H., eds. (2005). The Comprehensive Sourcebook of
Bacterial Protein Toxins, Third Edition (London: Academic Press).
Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A.,
Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. (2012). Synde-
can-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14,
677–685.
Baldari, C.T., Tonello, F., Paccani, S.R., and Montecucco, C. (2006). Anthrax
toxins: a paradigm of bacterial immune suppression. Trends Immunol. 27,
434–440.
Barre`s, C., Blanc, L., Bette-Bobillo, P., Andre´, S., Mamoun, R., Gabius, H.J.,
and Vidal, M. (2010). Galectin-5 is bound onto the surface of rat reticulocyte
exosomes and modulates vesicle uptake by macrophages. Blood 115,
696–705.
Boyer, A.E., Quinn, C.P., Woolfitt, A.R., Pirkle, J.L., McWilliams, L.G., Stamey,
K.L., Bagarozzi, D.A., Hart, J.C., Jr., and Barr, J.R. (2007). Detection and quan-
tification of anthrax lethal factor in serum by mass spectrometry. Anal. Chem.
79, 8463–8470.
Collier, R.J., and Young, J.A. (2003). Anthrax toxin. Annu. Rev. Cell Dev. Biol.
19, 45–70.
Danzer, K.M., Kranich, L.R., Ruf, W.P., Cagsal-Getkin, O., Winslow, A.R., Zhu,
L., Vanderburg, C.R., andMcLean, P.J. (2012). Exosomal cell-to-cell transmis-
sion of alpha synuclein oligomers. Mol. Neurodegener. 7, 42.
Falguie`res, T., Luyet, P.P., and Gruenberg, J. (2009). Molecular assemblies
and membrane domains in multivesicular endosome dynamics. Exp. Cell
Res. 315, 1567–1573.
Feld, G.K., Brown, M.J., and Krantz, B.A. (2012). Ratcheting up protein trans-
location with anthrax toxin. Protein science: a publication of the Protein
Society 21, 606–624.
Gibbings, D.J., Ciaudo, C., Erhardt, M., and Voinnet, O. (2009). Multivesicular
bodies associate with components of miRNA effector complexes and modu-
late miRNA activity. Nat. Cell Biol. 11, 1143–1149.
Gupta, P.K., Moayeri, M., Crown, D., Fattah, R.J., and Leppla, S.H. (2008).
Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS
One 3, e3130.
Ha, S.D., Ng, D., Lamothe, J., Valvano, M.A., Han, J., and Kim, S.O. (2007).
Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-
induced macrophage cell death. J. Biol. Chem. 282, 26275–26283.
Hsu, C., Morohashi, Y., Yoshimura, S., Manrique-Hoyos, N., Jung, S., Lauter-
bach,M.A., Bakhti, M., Grønborg,M., Mo¨bius,W., Rhee, J., et al. (2010). Regu-
lation of exosome secretion by Rab35 and its GTPase-activating proteins
TBC1D10A-C. J. Cell Biol. 189, 223–232.
Huotari, J., and Helenius, A. (2011). Endosomematuration. EMBO J. 30, 3481–
3500.996 Cell Reports 5, 986–996, November 27, 2013 ª2013 The AuthorsHurley, J.H., and Hanson, P.I. (2010). Membrane budding and scission by the
ESCRT machinery: it’s all in the neck. Nat. Rev. Mol. Cell Biol. 11, 556–566.
Husmann, M., Beckmann, E., Boller, K., Kloft, N., Tenzer, S., Bobkiewicz, W.,
Neukirch, C., Bayley, H., and Bhakdi, S. (2009). Elimination of a bacterial pore-
forming toxin by sequential endocytosis and exocytosis. FEBS Lett. 583,
337–344.
Kobayashi, T., Stang, E., Fang, K.S., de Moerloose, P., Parton, R.G., and
Gruenberg, J. (1998). A lipid associated with the antiphospholipid syndrome
regulates endosome structure and function. Nature 392, 193–197.
Krantz, B.A., Melnyk, R.A., Zhang, S., Juris, S.J., Lacy, D.B., Wu, Z., Finkel-
stein, A., and Collier, R.J. (2005). A phenylalanine clamp catalyzes protein
translocation through the anthrax toxin pore. Science 309, 777–781.
Levinsohn, J.L., Newman, Z.L., Hellmich, K.A., Fattah, R., Getz, M.A., Liu, S.,
Sastalla, I., Leppla, S.H., and Moayeri, M. (2012). Anthrax lethal factor cleav-
age of Nlrp1 is required for activation of the inflammasome. PLoS Pathog. 8,
e1002638.
Liu, S., and Leppla, S.H. (2003). Cell surface tumor endotheliummarker 8 cyto-
plasmic tail-independent anthrax toxin binding, proteolytic processing, olig-
omer formation, and internalization. J. Biol. Chem. 278, 5227–5234.
Liu, S., Zhang, Y., Moayeri, M., Liu, J., Crown, D., Fattah, R.J., Wein, A.N., Yu,
Z.X., Finkel, T., and Leppla, S.H. (2013). Key tissue targets responsible for
anthrax-toxin-induced lethality. Nature 501, 63–68.
Matsuo, H., Chevallier, J., Mayran, N., Le Blanc, I., Ferguson, C., Faure´, J.,
Blanc, N.S., Matile, S., Dubochet, J., Sadoul, R., et al. (2004). Role of LBPA
and Alix in multivesicular liposome formation and endosome organization.
Science 303, 531–534.
Moayeri, M., Crown, D., Jiao, G.S., Kim, S., Johnson, A., Leysath, C., and
Leppla, S.H. (2013). Small-molecule inhibitors of lethal factor protease activity
protect against anthrax infection. Antimicrob. Agents Chemother. 57, 4139–
4145.
Ostrowski, M., Carmo, N.B., Krumeich, S., Fanget, I., Raposo, G., Savina, A.,
Moita, C.F., Schauer, K., Hume, A.N., Freitas, R.P., et al. (2010). Rab27a and
Rab27b control different steps of the exosome secretion pathway. Nat. Cell
Biol. 12, 19–30.
Pons, V., Luyet, P.P., Morel, E., Abrami, L., van der Goot, F.G., Parton, R.G.,
and Gruenberg, J. (2008). Hrs and SNX3 functions in sorting and membrane
invagination within multivesicular bodies. PLoS Biol. 6, e214.
Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes,
microvesicles, and friends. J. Cell Biol. 200, 373–383.
Savina, A., Vidal, M., and Colombo, M.I. (2002). The exosome pathway in K562
cells is regulated by Rab11. J. Cell Sci. 115, 2505–2515.
Shoop, W.L., Xiong, Y., Wiltsie, J., Woods, A., Guo, J., Pivnichny, J.V., Fel-
cetto, T., Michael, B.F., Bansal, A., Cummings, R.T., et al. (2005). Anthrax lethal
factor inhibition. Proc. Natl. Acad. Sci. USA 102, 7958–7963.
Slater, L.H., Hett, E.C., Clatworthy, A.E., Mark, K.G., and Hung, D.T. (2013).
CCT chaperonin complex is required for efficient delivery of anthrax toxin
into the cytosol of host cells. Proc. Natl. Acad. Sci. USA 110, 9932–9937.
Smith, H., and Keppie, J. (1954). Observations on experimental anthrax;
demonstration of a specific lethal factor produced in vivo by Bacillus anthracis.
Nature 173, 869–870.
Thoren, K.L., and Krantz, B.A. (2011). The unfolding story of anthrax toxin
translocation. Mol. Microbiol. 80, 588–595.
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F.,
Schwille, P., Bru¨gger, B., and Simons, M. (2008). Ceramide triggers budding
of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247.
van der Goot, G., and Young, J.A. (2009). Receptors of anthrax toxin and cell
entry. Mol. Aspects Med. 30, 406–412.
Vella, L.J., Sharples, R.A., Lawson, V.A., Masters, C.L., Cappai, R., and Hill,
A.F. (2007). Packaging of prions into exosomes is associated with a novel
pathway of PrP processing. J. Pathol. 211, 582–590.
